Opinion|Videos|September 11, 2024
Central Precocious Puberty Treatment Starts, Discontinuations and Misconceptions
Experts address common misconceptions about the timing of central precocious puberty treatment initiation and discontinuation, highlighting research on outcomes for therapy started before age 7 and continued beyond age 12.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are common misconceptions regarding the timing of therapy initiation and discontinuation?
- What has research shown regarding outcomes for initiating therapy before age 7 years or discontinuing therapy after age 12 years?
- What consideration should clinicians give about the time to first menses after treatment cessation?
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
CDC updates website, opens door for autism and vaccines link
2
Daniele De Luca, MD, discusses zelpultide alfa in neonates at high risk of bronchopulmonary dysplasia development
3
FDA grants 510(k) clearance for Clarity algorithm to detect electrographic seizures in newborns
4
Jonathan Flyer, MD, highlights the LEAD initiative to increase pediatric lipid screenings
5
